Altus Capital Partners today announced it has acquired ChoiceSpine. Financial terms of the transaction were not disclosed.
ChoiceSpine and Knox Spine (collectively, the Company) collaborates with physicians to develop new products which incorporate current medical technology with customised patient solutions. ChoiceSpine products include minimally invasive, cervical, thoracolumbar, interbody, lateral, and biologics kits and implants that increase procedural efficiency and efficacy.
Management will continue to invest in the expansion of the business. Altus Capital partner Heidi Goldstein added, “We look forward to working with Founders Rick Henson and Marty Altshuler, who continue to invest alongside us in the Company, in further capitalising on the depth of their design and engineering capabilities, sales growth and momentum.”
“We have built a deep bench of talent that has led the company with an increased focus on product design and engineering which benefit so many patients experiencing spinal injuries,” said Rick Henson. “We look forward to working with Altus in further developing our offerings as well as expanding into new product verticals to continue to grow the company and provide patient solutions for the treatment of spinal disorders,” added Marty Altshuler.
This is Altus’ third acquisition in less than two years and its second in the medical technology space. The firm successfully completed the tender offer for all of the outstanding shares of common stock of MGC Diagnostics Corporation (MGC), a global medical technology company dedicated to cardiorespiratory health solutions in December 2017, and the acquisition of Max Environmental Technologies, an integrated environmental solutions company, in February, 2017.